Crude incident outcome event numbers and percentages after revascularization at the baseline in diabetic (PCI n = 20 118; CABG n = 12 900; total n = 33 018) and non-diabetic (PCI n = 69 375; CABG n = 36 849; total n = 106 224) patients grouped by revascularisation procedure in the time points of 28 days, 1 year and 3 yearsa
| . | 28 days . | 1 year . | 3 year . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | PCI . | CABG . | Total . | PCI . | CABG . | Total . | PCI . | CABG . | Total . |
| All-cause deaths | |||||||||
| Non-diabetic | 1534 (2.2%) | 1023 (2.8%) | 2557 (2.4%) | 3253 (4.7%) | 1808 (4.9%) | 5061 (4.8%) | 6052 (8.7%) | 3072 (8.3%) | 9124 (8.6%) |
| Diabetic | 736 (3.7%) | 462 (3.6%) | 1198 (3.6%) | 1764 (8.8%) | 925 (7.2%) | 2689 (8.1%) | 3373 (16.8%) | 1616 (12.5%) | 4989 (15.1%) |
| Cardiovascular deaths | |||||||||
| Non-diabetic | 1487 (2.1%) | 991 (2.7%) | 2478 (2.3%) | 2849 (4.1%) | 1655 (4.5%) | 4504 (4.2%) | 4847 (7.0%) | 2570 (7.0%) | 7417 (7.0%) |
| DM | 712 (3.5%) | 446 (3.5%) | 1158 (3.5%) | 1588 (7.9%) | 845 (6.6%) | 2433 (7.4%) | 2850 (14.2%) | 1369 (10.6%) | 4219 (12.8%) |
| Acute coronary syndrome | |||||||||
| Non-diabetic | 126 (0.3%) | 183 (0.5%) | 309 (0.3%) | 979 (1.4%) | 580 (1.6%) | 1559 (1.5%) | 1913 (2.8%) | 976 (2.6%) | 2889 (2.7%) |
| Diabetic | 58 (0.3%) | 84 (0.7%) | 142 (0.4%) | 494 (2.5%) | 252 (2.0%) | 746 (2.3%) | 1006 (5.0%) | 494 (3.8%) | 1500 (4.5%) |
| Stroke | |||||||||
| Non-diabetic | 15 (0.02%) | 48 (0.1%) | 63 (0.1%) | 518 (0.7%) | 418 (1.1%) | 936 (0.9%) | 1376 (2.0%) | 954 (2.6%) | 2330 (2.2%) |
| Diabetic | 6 (0.03%) | 18 (0.1%) | 24 (0.1%) | 231 (1.1%) | 183 (1.4%) | 414 (1.3%) | 597 (3.0%) | 414 (3.2%) | 1011 (3.1%) |
| Any CVDb | |||||||||
| Non-diabetic | 172 (0.2%) | 212 (0.6%) | 384 (0.4%) | 1176 (1.7%) | 809 (2.2%) | 1985 (1.9%) | 2290 (3.3%) | 1442 (3.9%) | 3732 (3.5%) |
| Diabetic | 66 (0.3%) | 89 (0.7%) | 155 (0.5%) | 490 (2.4%) | 340 (2.6%) | 830 (2.5%) | 1020 (5.1%) | 627 (4.9%) | 1647 (5.0%) |
| Heart failure | |||||||||
| Non-diabetic | 188 (0.3%) | 221 (0.6%) | 409 (0.4%) | 1101 (1.6%) | 701 (1.9%) | 1802 (1.7%) | 2055 (3.0%) | 1127 (3.1%) | 3182 (3.0%) |
| Diabetic | 71 (0.4%) | 102 (0.8%) | 173 (0.5%) | 497 (2.5%) | 306 (2.4%) | 803 (2.4%) | 983 (4.9%) | 537 (4.2%) | 1520 (4.6%) |
| Repeat revascularisation | |||||||||
| Non-diabetic | 104 (0.1%) | 20 (0.1%) | 124 (0.1%) | 4755 (6.9%) | 173 (0.5%) | 4928 (4.6%) | 6863 (9.9%) | 289 (0.8%) | 7152 (6.7%) |
| Diabetic | 41 (0.2%) | 6 (0.05%) | 47 (0.1%) | 1687 (8.4%) | 80 (0.6%) | 1767 (5.4%) | 2537 (12.6%) | 133 (1.0%) | 2670 (8.1%) |
| . | 28 days . | 1 year . | 3 year . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | PCI . | CABG . | Total . | PCI . | CABG . | Total . | PCI . | CABG . | Total . |
| All-cause deaths | |||||||||
| Non-diabetic | 1534 (2.2%) | 1023 (2.8%) | 2557 (2.4%) | 3253 (4.7%) | 1808 (4.9%) | 5061 (4.8%) | 6052 (8.7%) | 3072 (8.3%) | 9124 (8.6%) |
| Diabetic | 736 (3.7%) | 462 (3.6%) | 1198 (3.6%) | 1764 (8.8%) | 925 (7.2%) | 2689 (8.1%) | 3373 (16.8%) | 1616 (12.5%) | 4989 (15.1%) |
| Cardiovascular deaths | |||||||||
| Non-diabetic | 1487 (2.1%) | 991 (2.7%) | 2478 (2.3%) | 2849 (4.1%) | 1655 (4.5%) | 4504 (4.2%) | 4847 (7.0%) | 2570 (7.0%) | 7417 (7.0%) |
| DM | 712 (3.5%) | 446 (3.5%) | 1158 (3.5%) | 1588 (7.9%) | 845 (6.6%) | 2433 (7.4%) | 2850 (14.2%) | 1369 (10.6%) | 4219 (12.8%) |
| Acute coronary syndrome | |||||||||
| Non-diabetic | 126 (0.3%) | 183 (0.5%) | 309 (0.3%) | 979 (1.4%) | 580 (1.6%) | 1559 (1.5%) | 1913 (2.8%) | 976 (2.6%) | 2889 (2.7%) |
| Diabetic | 58 (0.3%) | 84 (0.7%) | 142 (0.4%) | 494 (2.5%) | 252 (2.0%) | 746 (2.3%) | 1006 (5.0%) | 494 (3.8%) | 1500 (4.5%) |
| Stroke | |||||||||
| Non-diabetic | 15 (0.02%) | 48 (0.1%) | 63 (0.1%) | 518 (0.7%) | 418 (1.1%) | 936 (0.9%) | 1376 (2.0%) | 954 (2.6%) | 2330 (2.2%) |
| Diabetic | 6 (0.03%) | 18 (0.1%) | 24 (0.1%) | 231 (1.1%) | 183 (1.4%) | 414 (1.3%) | 597 (3.0%) | 414 (3.2%) | 1011 (3.1%) |
| Any CVDb | |||||||||
| Non-diabetic | 172 (0.2%) | 212 (0.6%) | 384 (0.4%) | 1176 (1.7%) | 809 (2.2%) | 1985 (1.9%) | 2290 (3.3%) | 1442 (3.9%) | 3732 (3.5%) |
| Diabetic | 66 (0.3%) | 89 (0.7%) | 155 (0.5%) | 490 (2.4%) | 340 (2.6%) | 830 (2.5%) | 1020 (5.1%) | 627 (4.9%) | 1647 (5.0%) |
| Heart failure | |||||||||
| Non-diabetic | 188 (0.3%) | 221 (0.6%) | 409 (0.4%) | 1101 (1.6%) | 701 (1.9%) | 1802 (1.7%) | 2055 (3.0%) | 1127 (3.1%) | 3182 (3.0%) |
| Diabetic | 71 (0.4%) | 102 (0.8%) | 173 (0.5%) | 497 (2.5%) | 306 (2.4%) | 803 (2.4%) | 983 (4.9%) | 537 (4.2%) | 1520 (4.6%) |
| Repeat revascularisation | |||||||||
| Non-diabetic | 104 (0.1%) | 20 (0.1%) | 124 (0.1%) | 4755 (6.9%) | 173 (0.5%) | 4928 (4.6%) | 6863 (9.9%) | 289 (0.8%) | 7152 (6.7%) |
| Diabetic | 41 (0.2%) | 6 (0.05%) | 47 (0.1%) | 1687 (8.4%) | 80 (0.6%) | 1767 (5.4%) | 2537 (12.6%) | 133 (1.0%) | 2670 (8.1%) |
aAll-cause mortality and cardiovascular mortality are without exclusions. For the other outcomes, persons with the same event prior to baseline have been excluded from the analyses. CABG, coronary artery bypass surgery; CVD, cardiovascular disease event; Diabetic patients (including both type I and II); PCI, percutaneous coronary intervention.
bAny CVD defined as an incident event of any of the following: ACS, stroke, or heart failure (excluding cases with any prevalent CVD, either ACS, stroke, or heart failure, before baseline).
Crude incident outcome event numbers and percentages after revascularization at the baseline in diabetic (PCI n = 20 118; CABG n = 12 900; total n = 33 018) and non-diabetic (PCI n = 69 375; CABG n = 36 849; total n = 106 224) patients grouped by revascularisation procedure in the time points of 28 days, 1 year and 3 yearsa
| . | 28 days . | 1 year . | 3 year . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | PCI . | CABG . | Total . | PCI . | CABG . | Total . | PCI . | CABG . | Total . |
| All-cause deaths | |||||||||
| Non-diabetic | 1534 (2.2%) | 1023 (2.8%) | 2557 (2.4%) | 3253 (4.7%) | 1808 (4.9%) | 5061 (4.8%) | 6052 (8.7%) | 3072 (8.3%) | 9124 (8.6%) |
| Diabetic | 736 (3.7%) | 462 (3.6%) | 1198 (3.6%) | 1764 (8.8%) | 925 (7.2%) | 2689 (8.1%) | 3373 (16.8%) | 1616 (12.5%) | 4989 (15.1%) |
| Cardiovascular deaths | |||||||||
| Non-diabetic | 1487 (2.1%) | 991 (2.7%) | 2478 (2.3%) | 2849 (4.1%) | 1655 (4.5%) | 4504 (4.2%) | 4847 (7.0%) | 2570 (7.0%) | 7417 (7.0%) |
| DM | 712 (3.5%) | 446 (3.5%) | 1158 (3.5%) | 1588 (7.9%) | 845 (6.6%) | 2433 (7.4%) | 2850 (14.2%) | 1369 (10.6%) | 4219 (12.8%) |
| Acute coronary syndrome | |||||||||
| Non-diabetic | 126 (0.3%) | 183 (0.5%) | 309 (0.3%) | 979 (1.4%) | 580 (1.6%) | 1559 (1.5%) | 1913 (2.8%) | 976 (2.6%) | 2889 (2.7%) |
| Diabetic | 58 (0.3%) | 84 (0.7%) | 142 (0.4%) | 494 (2.5%) | 252 (2.0%) | 746 (2.3%) | 1006 (5.0%) | 494 (3.8%) | 1500 (4.5%) |
| Stroke | |||||||||
| Non-diabetic | 15 (0.02%) | 48 (0.1%) | 63 (0.1%) | 518 (0.7%) | 418 (1.1%) | 936 (0.9%) | 1376 (2.0%) | 954 (2.6%) | 2330 (2.2%) |
| Diabetic | 6 (0.03%) | 18 (0.1%) | 24 (0.1%) | 231 (1.1%) | 183 (1.4%) | 414 (1.3%) | 597 (3.0%) | 414 (3.2%) | 1011 (3.1%) |
| Any CVDb | |||||||||
| Non-diabetic | 172 (0.2%) | 212 (0.6%) | 384 (0.4%) | 1176 (1.7%) | 809 (2.2%) | 1985 (1.9%) | 2290 (3.3%) | 1442 (3.9%) | 3732 (3.5%) |
| Diabetic | 66 (0.3%) | 89 (0.7%) | 155 (0.5%) | 490 (2.4%) | 340 (2.6%) | 830 (2.5%) | 1020 (5.1%) | 627 (4.9%) | 1647 (5.0%) |
| Heart failure | |||||||||
| Non-diabetic | 188 (0.3%) | 221 (0.6%) | 409 (0.4%) | 1101 (1.6%) | 701 (1.9%) | 1802 (1.7%) | 2055 (3.0%) | 1127 (3.1%) | 3182 (3.0%) |
| Diabetic | 71 (0.4%) | 102 (0.8%) | 173 (0.5%) | 497 (2.5%) | 306 (2.4%) | 803 (2.4%) | 983 (4.9%) | 537 (4.2%) | 1520 (4.6%) |
| Repeat revascularisation | |||||||||
| Non-diabetic | 104 (0.1%) | 20 (0.1%) | 124 (0.1%) | 4755 (6.9%) | 173 (0.5%) | 4928 (4.6%) | 6863 (9.9%) | 289 (0.8%) | 7152 (6.7%) |
| Diabetic | 41 (0.2%) | 6 (0.05%) | 47 (0.1%) | 1687 (8.4%) | 80 (0.6%) | 1767 (5.4%) | 2537 (12.6%) | 133 (1.0%) | 2670 (8.1%) |
| . | 28 days . | 1 year . | 3 year . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | PCI . | CABG . | Total . | PCI . | CABG . | Total . | PCI . | CABG . | Total . |
| All-cause deaths | |||||||||
| Non-diabetic | 1534 (2.2%) | 1023 (2.8%) | 2557 (2.4%) | 3253 (4.7%) | 1808 (4.9%) | 5061 (4.8%) | 6052 (8.7%) | 3072 (8.3%) | 9124 (8.6%) |
| Diabetic | 736 (3.7%) | 462 (3.6%) | 1198 (3.6%) | 1764 (8.8%) | 925 (7.2%) | 2689 (8.1%) | 3373 (16.8%) | 1616 (12.5%) | 4989 (15.1%) |
| Cardiovascular deaths | |||||||||
| Non-diabetic | 1487 (2.1%) | 991 (2.7%) | 2478 (2.3%) | 2849 (4.1%) | 1655 (4.5%) | 4504 (4.2%) | 4847 (7.0%) | 2570 (7.0%) | 7417 (7.0%) |
| DM | 712 (3.5%) | 446 (3.5%) | 1158 (3.5%) | 1588 (7.9%) | 845 (6.6%) | 2433 (7.4%) | 2850 (14.2%) | 1369 (10.6%) | 4219 (12.8%) |
| Acute coronary syndrome | |||||||||
| Non-diabetic | 126 (0.3%) | 183 (0.5%) | 309 (0.3%) | 979 (1.4%) | 580 (1.6%) | 1559 (1.5%) | 1913 (2.8%) | 976 (2.6%) | 2889 (2.7%) |
| Diabetic | 58 (0.3%) | 84 (0.7%) | 142 (0.4%) | 494 (2.5%) | 252 (2.0%) | 746 (2.3%) | 1006 (5.0%) | 494 (3.8%) | 1500 (4.5%) |
| Stroke | |||||||||
| Non-diabetic | 15 (0.02%) | 48 (0.1%) | 63 (0.1%) | 518 (0.7%) | 418 (1.1%) | 936 (0.9%) | 1376 (2.0%) | 954 (2.6%) | 2330 (2.2%) |
| Diabetic | 6 (0.03%) | 18 (0.1%) | 24 (0.1%) | 231 (1.1%) | 183 (1.4%) | 414 (1.3%) | 597 (3.0%) | 414 (3.2%) | 1011 (3.1%) |
| Any CVDb | |||||||||
| Non-diabetic | 172 (0.2%) | 212 (0.6%) | 384 (0.4%) | 1176 (1.7%) | 809 (2.2%) | 1985 (1.9%) | 2290 (3.3%) | 1442 (3.9%) | 3732 (3.5%) |
| Diabetic | 66 (0.3%) | 89 (0.7%) | 155 (0.5%) | 490 (2.4%) | 340 (2.6%) | 830 (2.5%) | 1020 (5.1%) | 627 (4.9%) | 1647 (5.0%) |
| Heart failure | |||||||||
| Non-diabetic | 188 (0.3%) | 221 (0.6%) | 409 (0.4%) | 1101 (1.6%) | 701 (1.9%) | 1802 (1.7%) | 2055 (3.0%) | 1127 (3.1%) | 3182 (3.0%) |
| Diabetic | 71 (0.4%) | 102 (0.8%) | 173 (0.5%) | 497 (2.5%) | 306 (2.4%) | 803 (2.4%) | 983 (4.9%) | 537 (4.2%) | 1520 (4.6%) |
| Repeat revascularisation | |||||||||
| Non-diabetic | 104 (0.1%) | 20 (0.1%) | 124 (0.1%) | 4755 (6.9%) | 173 (0.5%) | 4928 (4.6%) | 6863 (9.9%) | 289 (0.8%) | 7152 (6.7%) |
| Diabetic | 41 (0.2%) | 6 (0.05%) | 47 (0.1%) | 1687 (8.4%) | 80 (0.6%) | 1767 (5.4%) | 2537 (12.6%) | 133 (1.0%) | 2670 (8.1%) |
aAll-cause mortality and cardiovascular mortality are without exclusions. For the other outcomes, persons with the same event prior to baseline have been excluded from the analyses. CABG, coronary artery bypass surgery; CVD, cardiovascular disease event; Diabetic patients (including both type I and II); PCI, percutaneous coronary intervention.
bAny CVD defined as an incident event of any of the following: ACS, stroke, or heart failure (excluding cases with any prevalent CVD, either ACS, stroke, or heart failure, before baseline).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
